Gossamer Bio, Inc. (GOSS)

0.4557 +0.02 (+5.58%) USD  |  NASDAQ  |  Apr 15, 16:00
0.454 0.00 (0.00%) After-Hours: 18:34
More

Gossamer Bio Research and Development Expense (Annual) : 174.07M for Dec. 31, 2025

Research and Development Expense (Annual) Chart

View Research and Development Expense (Annual) for GOSS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Research and Development Expense (Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

R&D Expense Definition

View R&D Expense Definition
Start Trial

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (Annual) Range, Past 5 Years

View Research and Development Expense (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (Annual) Benchmarks

View Research and Development Expense (Annual) Benchmarks
Start Trial
Vanda Pharmaceuticals, Inc. 109.27M
Artelo Biosciences, Inc. 5.423M
Arvinas, Inc. 282.90M
Quince Therapeutics, Inc. 35.38M
Vir Biotechnology, Inc. 432.80M